NeuroQuant® MS performance evaluation

Quantitative measurements of lesion volume and lesion distribution have significant value for clinicians evaluating disease progression. Subjective measurements based on a clinician’s visual inspection and manual lesion segmentation are often vulnerable to inter-and intra-rater variability, resulting in low reproducibility. Thus, objective, automated lesion segmentation tools have been developed [1-3] to overcome these problems. Since the appearance of lesions may vary across different MRI protocols, incorporating multiple MRI studies provides more information to accurately delineate lesions.


Insights

19 December 2024

Elevating Neurological CT Precision and Efficiency

Learn how this powerful tool improves measurement accuracy, clinical confidence, and patient outcomes by streamlining workflows.

19 December 2024

OnQ Prostate: Advancing Prostate Cancer Imaging with OnQ Prostate

Discover how this advanced technology enhances diagnostic accuracy, reduces variability, and supports more informed clinical decisions.

19 December 2024

NeuroQuant Brain Tumor – Advancing Tumor Quantification in Clinical Practice

Discover how NeuroQuant® Brain Tumor can streamline tumor quantification, reduce manual workload, and support more precise decision-making.
Scroll to Top